Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials | Zendy

Ciara C. O’Sullivan | Zendy; Ian Bradbury | Zendy; Christine Campbell | Zendy; M. Spielmann | Zendy; Edith A. Perez | Zendy; Heikki Joensuu | Zendy; Joseph P. Costantino | Zendy; Suzette Delaloge | Zendy; Priya Rastogi | Zendy; Dimitrios Zardavas | Zendy; Karla V. Ballman | Zendy; Eileen Holmes | Zendy; Evandro de Azambuja | Zendy; Martine Piccart | Zendy; Jo Anne Zujewski | Zendy; Richard D. Gelber | Zendy

Open Access

Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials

Author(s) -

Ciara C. O’Sullivan,

Ian Bradbury,

Christine Campbell,

M. Spielmann,

Edith A. Perez,

Heikki Joensuu,

Joseph P. Costantino,

Suzette Delaloge,

Priya Rastogi,

Dimitrios Zardavas,

Karla V. Ballman,

Eileen Holmes,

Evandro de Azambuja,

Martine Piccart,

Jo Anne Zujewski,

Richard D. Gelber

Publication year - 2015

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2015.60.8620

Subject(s) - trastuzumab , medicine , breast cancer , oncology , cumulative incidence , adjuvant , incidence (geometry) , cancer , gastroenterology , cohort , physics , optics

We compared efficacy of trastuzumab versus no trastuzumab in patients with small (≤ 2 cm) human epidermal growth factor receptor 2 (HER2) -positive breast cancer treated in randomized trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog